A leap forward in research on CAR T cell therapy

by University of HelsinkiCredit: CC0 Public DomainIn cancer immunotherapy, cells in the patient's own immune system are activated to attack cancer cells. CAR T cell therapy has been one of th

Updated on: April 09,2024

A leap forward in research on CAR T cell therapy

by University of HelsinkiCredit: CC0 Public DomainIn cancer immunotherapy, cells in the patient's own immune system are activated to attack cancer cells. CAR T cell therapy has been one of th

Updated on:April 09,2024

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in

Updated on: June 01,2024

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in

Updated on:June 01,2024

FDA approves first interchangeable biosimilar for inflammatory diseases

(HealthDay)—The first interchangeable biosimilar product to Humira (adalimumab) was approved by the U.S. Food and Drug Administration on Oct. 15, the agency announced Monday.Cyltezo (adalimumab-adbm),

Updated on: June 17,2024

FDA approves first interchangeable biosimilar for inflammatory diseases

(HealthDay)—The first interchangeable biosimilar product to Humira (adalimumab) was approved by the U.S. Food and Drug Administration on Oct. 15, the agency announced Monday.Cyltezo (adalimumab-adbm),

Updated on:June 17,2024

Declining antibodies and immunity to COVID-19 – why the worry?

by Alexander (Sasha) Poltorak,The ConversationCredit: Pixabay/CC0 Public DomainMost people are aware that testing for antibodies in a person's blood can show if someone has had a specific di

Updated on: April 10,2024

Declining antibodies and immunity to COVID-19 – why the worry?

by Alexander (Sasha) Poltorak,The ConversationCredit: Pixabay/CC0 Public DomainMost people are aware that testing for antibodies in a person's blood can show if someone has had a specific di

Updated on:April 10,2024

Why inflammatory arthritis always recurs in certain joints

by Children's Hospital BostonCredit: Unsplash/CC0 Public DomainWhen joints flare up in people with rheumatoid arthritis and related diseases, the joints involved are often the same as those a

Updated on: June 17,2024

Why inflammatory arthritis always recurs in certain joints

by Children's Hospital BostonCredit: Unsplash/CC0 Public DomainWhen joints flare up in people with rheumatoid arthritis and related diseases, the joints involved are often the same as those a

Updated on:June 17,2024

COVID-19 can cause severe inflammation in the brain

by Albert Ludwigs University of FreiburgGraphical Abstract. Credit:Immunity(2021). DOI: 10.1016/j.immuni.2021.06.002Both during and after infection with the Coronavirus SARS-CoV-2, pa

Updated on: April 10,2024

COVID-19 can cause severe inflammation in the brain

by Albert Ludwigs University of FreiburgGraphical Abstract. Credit:Immunity(2021). DOI: 10.1016/j.immuni.2021.06.002Both during and after infection with the Coronavirus SARS-CoV-2, pa

Updated on:April 10,2024

New 3-D imaging analysis technique could lead to improved arthritis treatment

by University of CambridgeJoint space in hip, knee and ankle joints as analyzed by the JSM algorithm. Credit: Tom TurmezeiAn algorithm to monitor the joints of patients with arthritis, which coul

Updated on: May 29,2024

New 3-D imaging analysis technique could lead to improved arthritis treatment

by University of CambridgeJoint space in hip, knee and ankle joints as analyzed by the JSM algorithm. Credit: Tom TurmezeiAn algorithm to monitor the joints of patients with arthritis, which coul

Updated on:May 29,2024

The importance of treatment goals in PSA

by European Alliance of Associations for Rheumatology (EULAR)Credit: Pixabay/CC0 Public DomainPsA is a type of inflammatory arthritis linked to psoriasis—a chronic condition affecting the skin and nai

Updated on: March 24,2024

The importance of treatment goals in PSA

by European Alliance of Associations for Rheumatology (EULAR)Credit: Pixabay/CC0 Public DomainPsA is a type of inflammatory arthritis linked to psoriasis—a chronic condition affecting the skin and nai

Updated on:March 24,2024

Why COVID patients become critically ill

by University of AmsterdamCredit: Unsplash/CC0 Public DomainResearchers at Amsterdam UMC have discovered why patients become seriously ill after being infected with the coronavirus. They identifi

Updated on: April 09,2024

Why COVID patients become critically ill

by University of AmsterdamCredit: Unsplash/CC0 Public DomainResearchers at Amsterdam UMC have discovered why patients become seriously ill after being infected with the coronavirus. They identifi

Updated on:April 09,2024

CAR T cells suppress GI solid tumor cells, without toxicity to healthy tissue, in preclinical research

by University of PennsylvaniaCDH17 CARTs attack tumor but spare normal tissue. Credit: Penn MedicineChimeric antigen receptor (CAR) T cells can be remarkably effective in treating leukemias and l

Updated on: April 09,2024

CAR T cells suppress GI solid tumor cells, without toxicity to healthy tissue, in preclinical research

by University of PennsylvaniaCDH17 CARTs attack tumor but spare normal tissue. Credit: Penn MedicineChimeric antigen receptor (CAR) T cells can be remarkably effective in treating leukemias and l

Updated on:April 09,2024

Increased use of partial knee replacement could save the NHS £30 million per year

by University of OxfordCredit: NDORMSNew research from a randomised clinical trial published today inThe Lancetand funded by the National Institute for Health Research (NIHR) shows th

Updated on: March 28,2024

Increased use of partial knee replacement could save the NHS £30 million per year

by University of OxfordCredit: NDORMSNew research from a randomised clinical trial published today inThe Lancetand funded by the National Institute for Health Research (NIHR) shows th

Updated on:March 28,2024

Risankizumab safe, effective at 52 weeks for psoriatic arthritis

by Lori SolomonRisankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently publishe

Updated on: June 01,2024

Risankizumab safe, effective at 52 weeks for psoriatic arthritis

by Lori SolomonRisankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently publishe

Updated on:June 01,2024